Get the Stockscreener App
6.64
0.30%
-0.00
After Hours:
6.53
-0.11
-1.66%
Capsovision Inc stock is traded at $6.64, with a volume of 110.49K.
It is down -0.30% in the last 24 hours and up +9.06% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
See More
Previous Close:
$6.64
Open:
$6.68
24h Volume:
110.49K
Relative Volume:
0.40
Market Cap:
$331.26M
Revenue:
$13.55M
Net Income/Loss:
$-25.32M
P/E Ratio:
-12.25
EPS:
-0.542
Net Cash Flow:
-
1W Performance:
+0.76%
1M Performance:
+9.06%
6M Performance:
+16.14%
1Y Performance:
+0.00%
1-Day Range:
$6.385
$6.91
1-Week Range:
$6.29
$7.208
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.63 | 331.76M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
CapsoVision (CV) Q1 2026 Earnings: EPS Miss Raises Concerns Amid Operational UncertaintyProfitability Analysis - Newser
CapsoVision Inc. (CV) Gains 1.77% as Shares Test Key Resistance Near $7.23Community Pattern Alerts - Newser
CapsoVision Inc. (CV) Advances 1.18% as Price Moves Toward ResistanceHot Momentum Watchlist - Newser
CapsoVision (CV) Q1 2026 Miss: What Went WrongConsensus Beat Rate - Newser
CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026 - MSN
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
U.S. Smart Pills Market to Reach USD 619.10 Million by 2033 as - openPR.com
CapsoVision, Inc. (CV) AI-Powered Stock Analysis - Meyka
CapsoVision Reports Stable Q1 Revenue and Expands AI Medical Pipeline - HarianBasis.co
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 - Investing.com UK
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 By Investing.com - Investing.com South Africa
CapsoVision Q1 Earnings Call Highlights - sharewise.com
CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading - ChartMill
CAPSOVISION ($CV) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings call transcript: CapsoVision misses Q1 2026 EPS forecast, stock rises - Investing.com
Transcript: CapsoVision Q1 2026 Earnings Conference Call - Benzinga
CapsoVision Q1 2026 Earnings Call Transcript - MarketBeat
CapsoVision Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CapsoVision, Inc 1Q 2026: Revenue $2.79M, EPS $(0.15) — 10-Q Summary - TradingView
CapsoVision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CapsoVision Reports First Quarter 2026 Financial Results - Yahoo Finance UK
CapsoVision, Inc.Common Stock (Nasdaq:CV) Stock Quote - FinancialContent
User | times-online.comCapsoVision, Inc.Common Stock (Nasdaq:CV) Stock Quote - FinancialContent
CapsoVision Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
TradingKey - TradingKey
Number of shareholders of CapsoVision, Inc. – NASDAQ:CV - TradingView
Number of shareholders of CapsoVision, Inc. – DUS:H6U - TradingView
Earnings Preview: CapsoVision to Report Financial Results Post-market on May 14 - Moomoo
What makes CapsoVision (CV) different from its competitors? (Breakout Watch) 2026-05-07Delta Trends - newser.com
CapsoVision (NASDAQ: CV) amendment reports 5.10M shares owned by Harari group - Stock Titan
CapsoVision (CV) sales head exercises 107,357 options, boosts share stake - Stock Titan
CapsoVision (CV) price target decreased by 16.00% to 10.71 - MSN
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 - GlobeNewswire
CapsoVision (CV) 2026 proxy: director elections, Baker Tilly ratification and pay - Stock Titan
Capsule Endoscope Systems Market Climbs to USD 0.6 Billion - openPR.com
CapsoVision (CV) Stock Outlook | Q4 2025: EPS Tops ViewsUser Trade Ideas - Newser
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership - Yahoo Finance
CV (CapsoVision) reports far narrower Q4 2025 loss than estimates, shares stay flat in today’s trading.Net Margin - Cổng thông tin điện tử Tỉnh Sơn La
[EFFECT] CapsoVision, Inc SEC Filing - Stock Titan
CapsoVision (NASDAQ: CV) registers 2.87M PIPE shares for resale - Stock Titan
CapsoVision (CV) Stock Initiates Position (Froths) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
CapsoVision (CV) Stock Signal Based Trade (+11.30%) 2026-04-18Stock Distribution - Cổng thông tin điện tử Tỉnh Sơn La
Capsovision Incfiles prospectus for resale of 2,867,089 common shares by selling stockholdersSEC filing - marketscreener.com
Existing holders of CapsoVision (NASDAQ: CV) register 2.87M PIPE shares for resale - Stock Titan
Ching Hang Shen Net Worth (2026) - GuruFocus
CapsoVision (CV) ownership: Shen Ching Hang holds 6.40M shares, Star One indirect - Stock Titan
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Capsovision Inc Stock (CV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Atkinson Douglas Patrick | Head of Global Sales |
May 05 '26 |
Option Exercise |
0.57 |
34,786 |
19,692 |
107,357 |
| Harari Michele | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
59,043 |
| GOUW JULIA S | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Imperial Joanne Carol | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| King Wen-Herng Henry | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
23,597 |
| Kuo Hui Ying | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
13,241 |
| Tsai Chen Lung | Director |
Dec 31 '25 |
Option Exercise |
10.69 |
2,887 |
30,862 |
2,887 |
| Petersen Rebecca Ann | Director of Clinical Affairs |
Aug 18 '25 |
Option Exercise |
0.37 |
24,834 |
9,097 |
24,834 |
1.35%
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):